EMCC European Monitoring Centre on Change



Geographic Location

Country: Slovenia
Region: Osrednjeslovenska; Slovenija
Location of affected unit(s): Mengeš, Zagorje ob Savi


Sector: Manufacturing
Manufacture of pharmaceuticals, medicinal chemical and botanical products
21.10 - Manufacture of basic pharmaceutical products
Number Employed: 4797
Group: Novartis

Employment Effects

Announcement Date: 13-10-2022
Type of Restructuring: Business expansion
Employment Effect Start: 01-11-2022
Foreseen End Date: 31-12-2023
Planned Job Creation: 100

Additional Information

The pharmaceutical company Lek, located in Ljubljana and part of the Swiss-based Sandoz group (Novartis), has announced a plan for creating 100 new jobs at its Biopharmaceutics unit in Mengeš, which currently has 300 employees. The unit has been awarded ‘Factory of the Year 2022’ for most successful implementation of the Industry 4.0 concept among Slovenian companies, by standing out with its technological advances in production, employee care, concern for sustainable development and business. The announcement for the recruitment of 100 new employees was made by the production unit director, Polonca Kovač, during her award acceptance speech. Kovač also announced that the factory- a producer of active ingredients for biologics and biosimilars- plans to quadruple the production capacity of one of its subunits in Zagorje ob Savi within the next two years (2023 and 2024).

Currently the company employs 4797 people in Slovenia.

Previous business restructurings were recorded in the ERM database in 2020, with 140 jobs created (Lek-2020-SI), in 2019, with 320 jobs cut (Lek-2019-SI) and in 2016, with 100 jobs created (Lek-2016-SI).